Form D — Shuttle Pharmaceuticals Holdings, Inc.
0001641172-25-016626 · filed 2025-06-26
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $4,250,000
- Total sold
- $4,250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Shuttle Pharmaceuticals Holdings, Inc.
- CIK
- 1757499
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 401 PROFESSIONAL DRIVE
GAITHERSBURG, MD 20879 - Phone
- (240) 403-4212
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Cooper · Executive OfficerGaithersburg, MD Find on LinkedIn ↗
-
Peter Dritschilo · Executive OfficerGaithersburg, MD Find on LinkedIn ↗
-
Mira Jung · Executive OfficerGaithersburg, MD Find on LinkedIn ↗
-
Tyvin Rich · Executive OfficerGaithersburg, MD Find on LinkedIn ↗
-
Timothy Lorber · Executive OfficerGaithersburg, MD Find on LinkedIn ↗
-
George Scorcis · DirectorGaithersburg, MD Find on LinkedIn ↗
-
Steven Richards · DirectorGaithersburg, MD Find on LinkedIn ↗
-
Oleh Nabyt · DirectorGaithersburg, MD Find on LinkedIn ↗
-
Joseph Tung · DirectorGaithersburg, MD Find on LinkedIn ↗
View original on SEC EDGAR.